JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB141041

Mitoxantrone dihydrochloride, Type II topoisomerase inhibitor

Be the first to review this product! Submit a review

|

(2 Publications)

MW 517.4 Da, Purity >98%. Type II topoisomerase inhibitor (IC50 = 50 nM). Able to inhibit DNA and protein synthesis, and induce both DNA strand breakage and cross linkage. Antineoplastic, immunomodulatory and chemotherapeutic action.
1 Images
Chemical Structure - Mitoxantrone dihydrochloride, Type II topoisomerase inhibitor (AB141041)
  • Chemical Structure

Lab

Chemical Structure - Mitoxantrone dihydrochloride, Type II topoisomerase inhibitor (AB141041)

2D chemical structure image of ab141041, Mitoxantrone dihydrochloride, Type II topoisomerase inhibitor

Key facts

CAS number

70476-82-3

Purity

>98%

Form

Solid

form

Molecular weight

517.4 Da

Molecular formula

C<sub>2</sub><sub>2</sub>H<sub>3</sub><sub>0</sub>Cl<sub>2</sub>N<sub>4</sub>O<sub>6</sub>

PubChem

51082

Nature

Synthetic

Solubility

pH 9 Borate buffer < 1 (mg/mL)

Soluble in DMSO to 100 mM

Soluble in water to 10 mM

Biochemical name

Mitoxantrone hydrochloride

Biological description

Type II topoisomerase inhibitor (IC50 = 50 nM). Able to inhibit DNA and protein synthesis, and induce both DNA strand breakage and cross linkage. Antineoplastic, immunomodulatory and chemotherapeutic action.

Canonical smiles

C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO.Cl.Cl

InChi

InChI=1S/C22H28N4O6.2ClH/c27-11-9-23-5-7-25-13-1-2-14(26-8-6-24-10-12-28)18-17(13)21(31)19-15(29)3-4-16(30)20(19)22(18)32;;/h1-4,23-30H,5-12H2;2*1H

InChiKey

ZAHQPTJLOCWVPG-UHFFFAOYSA-N

IUPAC Name

1,4-dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione;dihydrochloride

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
Ambient
Appropriate long-term storage conditions
Ambient
Storage information
Store under desiccating conditions|The product can be stored for up to 12 months

Product protocols

Publications (2)

Recent publications for all applications. Explore the full list and refine your search

eLife 13: PubMed39641975

2024

Reversing protonation of weakly basic drugs greatly enhances intracellular diffusion and decreases lysosomal sequestration.

Applications

Unspecified application

Species

Unspecified reactive species

Debabrata Dey,Shir Marciano,Anna Poryval,Ondřej Groborz,Lucie Wohlrabova,Tomás Slanina,Gideon Schreiber

EMBO molecular medicine 12:e10812 PubMed31930723

2020

Synthetic lethality between VPS4A and VPS4B triggers an inflammatory response in colorectal cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Ewelina Szymańska,Paulina Nowak,Krzysztof Kolmus,Magdalena Cybulska,Krzysztof Goryca,Edyta Derezińska-Wołek,Anna Szumera-Ciećkiewicz,Marta Brewińska-Olchowik,Aleksandra Grochowska,Katarzyna Piwocka,Monika Prochorec-Sobieszek,Michał Mikula,Marta Miączyńska
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com